Luo Wei-Tzu, Kao Chih-Chin, Chang Che-Mai, Wu Mei-Yi, Liao Hsin-Ni, Ho Szu-Ying, Tsai I-Lin, Chou Sheng-Po, Wu Mai-Szu, Chang Wei-Chiao
Department of Clinical Pharmacy, School of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan; Taipei Medical University Research Center of Urology and Kidney, Taipei Medical University, Taipei 110, Taiwan.
Int Immunopharmacol. 2025 Jul 12;163:115187. doi: 10.1016/j.intimp.2025.115187.
Immunoglobulin A nephropathy (IgAN) or Berger's disease is an autoimmune kidney disease. It is caused by the deposition of immunoglobulin A (IgA) in the kidney that results in glomerulonephritis and a gradual loss of renal functions. How antibodies/B cell receptors (BCRs) are involved in the pathogenesis of IgAN remains unclear, thus, to investigate BCR repertoire in IgAN is crucial to understand pathophysiological mechanisms of IgAN.
In this study, whole BCR repertoire, including BCR heavy (IGA, IGD, IGE, IGG, and IGM) and light (IGL and IGK) chains, were comprehensively profiled and analyzed in IgAN and non-IgA nephropathy (non-IgAN) patients through immune receptor sequencing.
We identified a significantly higher diversity in the BCR light chain repertoire in IgAN patients compared to non-IgAN patients. Additionally, a higher usage of lambda light chains was observed in IgAN patients. Further network analysis indicated a greater diversification of the BCR lambda light chain repertoire in IgAN patients and identified IgAN-associated lambda light chain clonal lineages with the differentially utilized IGLV gene.
These findings indicated significantly distinct features of BCR light chain repertoire in IgAN patients and suggested that characteristics of BCR light chain repertoire are very likely as potential biomarkers for the diagnosis of IgAN.
免疫球蛋白A肾病(IgAN)或伯杰氏病是一种自身免疫性肾脏疾病。它是由免疫球蛋白A(IgA)在肾脏中的沉积引起的,这会导致肾小球肾炎和肾功能的逐渐丧失。抗体/B细胞受体(BCR)如何参与IgAN的发病机制仍不清楚,因此,研究IgAN中的BCR库对于理解IgAN的病理生理机制至关重要。
在本研究中,通过免疫受体测序对IgAN患者和非IgA肾病(非IgAN)患者的整个BCR库进行了全面分析,包括BCR重链(IGA、IGD、IGE、IGG和IGM)和轻链(IGL和IGK)。
我们发现,与非IgAN患者相比,IgAN患者的BCR轻链库多样性显著更高。此外,在IgAN患者中观察到λ轻链的使用频率更高。进一步的网络分析表明,IgAN患者的BCR λ轻链库更加多样化,并鉴定出与IgAN相关的λ轻链克隆谱系,其IGLV基因的使用存在差异。
这些发现表明IgAN患者的BCR轻链库具有明显不同的特征,并提示BCR轻链库的特征很可能作为IgAN诊断的潜在生物标志物。